RxDoctor Payments Data

Patrick Vollmer

Optometrist · Columbia, SCNPI 1952784928

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $34,813 of the $49,189 with a category attached, or 70.8%. Bausch & Lomb Americas Inc. accounts for 86.1% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2024 at $26,515 and has fallen 81.9% since, to $4,809 in 2025. Among optometrist clinicians in SC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$49,189in general payments, 2019–2025

Across 143 payments — averaging $343.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bausch & Lomb Americas Inc.$42K
  • Tarsus Pharmaceuticals, Inc.$5K
  • Alcon$616
  • Harrow Eye, LLC$465
  • Bausch & Lomb, A Division Of Bausch Health US, LLC$342
  • Novartis$192
  • plus $480 from 6 others
$1,741,622in research payments, 2019–2025

Across 116 payments — averaging $15,014 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Bausch & Lomb Americas Inc.$866K
  • Tarsus Pharmaceuticals, Inc.$428K
  • Alcon Research LLC$299K
  • Biotissue Holdings Inc.$112K
  • Roche TCRC, Inc.$14K
  • AbbVie$8K
  • plus $15K from 2 others

What the payments were for

  • Consulting fees$3,6007%
  • Speaking & faculty fees$34,81371%
  • Travel & lodging$6,04412%
  • Food & beverage$4,72810%
  • Education$50%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$49,189 in reported general payments places this provider in the 95th percentile of 653 optometrist providers in South Carolina.

See all optometrist providers in South Carolina

Medicare billing

Part B allowed, 2024
$41,391
Medicare patients
216
Services billed
436

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Latanoprost228$1,594
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha60$792
Prednisolone Acetate25$769
Doxycycline Hyclate20$599
Timolol Maleate57$266
Cephalexin12$56
Prednisone12$16

Paid to pharmacies, not to this prescriber.

Other optometrist in Columbia

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →